| Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder (NCT05271084) | Hawler Medical University | 2021-11-10 |
| Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus (NCT05039840) | Sanofi | 2021-11-10 |
| Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac (NCT05205096) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-11-10 |
| Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine (NCT05238649) | Livzon Pharmaceutical Group Inc. | 2021-11-10 |
| Noise-Induced Hearing Loss-Acute Exposure Treatment (UA) (NCT04774250) | Washington University School of Medicine | 2021-11-10 |
| A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours (NCT05057013) | Cancer Research UK | 2021-11-10 |
| Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia (NCT05148884) | Neurolixis SAS | 2021-11-09 |
| Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients (NCT05114421) | M.D. Anderson Cancer Center | 2021-11-09 |
| (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis (NCT04996875) | Cogent Biosciences, Inc. | 2021-11-09 |
| Phase Ⅰ/Ⅱ Study of the HS-10365 in Patients With Advanced Solid Tumors (NCT05207787) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2021-11-09 |
| A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction (NCT05013385) | Boehringer Ingelheim | 2021-11-09 |
| Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease (NCT04780399) | Dongzhimen Hospital, Beijing | 2021-11-09 |
| A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation (NCT05119933) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2021-11-09 |
| Effect of GLP-1 Receptor Agonists on Trabecular Bone Score (NCT04964388) | University of Mississippi Medical Center | 2021-11-09 |
| Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma (NCT04892446) | Gilead Sciences | 2021-11-09 |
| Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients (NCT04539236) | Mikkael Sekeres, MD | 2021-11-09 |
| Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer (NCT04996771) | Sun Yat-sen University | 2021-11-09 |
| Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma (NCT04113226) | Centre Hospitalier Universitaire, Amiens | 2021-11-09 |
| To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia (NCT06409650) | Suzhou Koshine Biomedica, Inc. | 2021-11-09 |
| A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study (NCT05130437) | ModernaTX, Inc. | 2021-11-09 |
| Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA) (NCT05159778) | HiberCell, Inc. | 2021-11-09 |
| Study Comparing Two Versus Three Active MDMA-assisted Sessions in U.S. Military Veterans With Chronic PTSD (NCT04784143) | Resilient Pharmaceuticals | 2021-11-08 |
| Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION (NCT04901988) | The Christie NHS Foundation Trust | 2021-11-08 |
| A Phase 2 Bridging Study to Assess the New Formulation of ETVAX (NCT05178134) | Scandinavian Biopharma AB | 2021-11-08 |
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors (NCT04851119) | Children's Oncology Group | 2021-11-08 |
| Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT (NCT05497102) | Samsung Medical Center | 2021-11-08 |
| Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy (NCT05076838) | Neurelis, Inc. | 2021-11-08 |
| Dapagliflozin in Non-diabetic Stage IV CKD (NCT04794517) | Mario Negri Institute for Pharmacological Research | 2021-11-08 |
| A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder (NCT05062577) | Astellas Pharma Global Development, Inc. | 2021-11-08 |
| Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (NCT05105841) | AbbVie | 2021-11-08 |
| A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC) (NCT04907539) | Redx Pharma Ltd | 2021-11-08 |
| Phase I/II Clinical Trial of LBL-015 for Injection (NCT05107011) | Nanjing Leads Biolabs Co.,Ltd | 2021-11-08 |
| Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications (NCT05207189) | TBF Genie Tissulaire | 2021-11-08 |
| A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection (NCT04981665) | Zhejiang University | 2021-11-08 |
| A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures (NCT05159908) | Neurocrine Biosciences | 2021-11-08 |
| COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease (NCT05081388) | Regeneron Pharmaceuticals | 2021-11-08 |
| Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity (NCT05017571) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2021-11-08 |
| Naxitamab and GM-CSF in Combination With IT in Patients With High-Risk Neuroblastoma (NCT04560166) | Y-mAbs Therapeutics | 2021-11-08 |
| Hyperbaric Oxygen for Long COVID-19 Pulmonary Sequela (NCT04905888) | Peter Lindholm | 2021-11-08 |
| Assessing Immune Response of Different COVID-19 Vaccines in Older Adults (NCT05160766) | Oliver Cornely, MD | 2021-11-08 |
| Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment (NCT05126472) | Memorial Sloan Kettering Cancer Center | 2021-11-08 |
| A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis (NCT04911751) | KoBioLabs | 2021-11-08 |
| Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) (NCT05065216) | DiaMedica Therapeutics Inc | 2021-11-07 |
| Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients (NCT06051565) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-11-06 |
| Assessment of the Effects and Tolerability of RD03/2016 for the Treatment of Bacterial Conjunctivitis in Adults (NCT06616922) | NTC srl | 2021-11-05 |
| ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02) (NCT05041972) | Ambrx, Inc. | 2021-11-05 |
| A Study of NDI 1150-101 in Patients With Solid Tumors (NCT05128487) | Nimbus Saturn, Inc. | 2021-11-05 |
| Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19 (NCT04513184) | Edda Sciutto Conde | 2021-11-05 |
| Gene Transfer Clinical Trial for Krabbe Disease (NCT04693598) | Forge Biologics, Inc | 2021-11-05 |
| Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer. (NCT05116917) | Herlev Hospital | 2021-11-05 |
| Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study (NCT04311502) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-11-05 |
| A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC (NCT05336721) | Chipscreen Biosciences, Ltd. | 2021-11-05 |
| Anlotinib Plus Penpulimab (AK105) for Chemo-refractory Metastatic Colorectal Cancer:ALTER-C003 (NCT04970914) | Peking Union Medical College Hospital | 2021-11-05 |
| Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma (NCT05122091) | Guangxi Medical University | 2021-11-05 |
| HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure (NCT05135364) | Yue Han | 2021-11-05 |
| Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus) (NCT05177133) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2021-11-05 |
| Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) (NCT05103332) | Alnylam Pharmaceuticals | 2021-11-05 |
| CAR-T Followed by Bispecific Antibodies (NCT04889716) | Abramson Cancer Center at Penn Medicine | 2021-11-05 |
| Open-Label Study of 18F-mFBG for Imaging Myocardial Sympathetic Innervation (NCT04535193) | Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) | 2021-11-05 |
| Effectiveness of Ketamine Administered by Mesotherapy in Complex Regional Pain Syndrome Type 1 (CRPS1) (NCT04650074) | Hospices Civils de Lyon | 2021-11-05 |
| A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis (NCT04781543) | Amgen | 2021-11-05 |
| Characterization of Hamstring and Quadriceps Neuromuscular Fatigue After Soccer Game (NCT04943510) | University Hospital, Strasbourg, France | 2021-11-04 |
| Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis (NCT05098522) | Revolo Biotherapeutics | 2021-11-04 |
| "CHANGE COVID-19 Severity" (NCT04941703) | Vanderbilt University Medical Center | 2021-11-04 |
| Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell) (NCT05109598) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2021-11-04 |
| A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis (NCT05061693) | Incyte Corporation | 2021-11-04 |
| Gene Therapy for IGHMBP2-Related Diseases (NCT05152823) | Megan Waldrop | 2021-11-04 |
| Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer (NCT04171622) | M.D. Anderson Cancer Center | 2021-11-04 |
| Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms (NCT05000346) | Aquilon Pharmaceuticals S.A. | 2021-11-04 |
| A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. (NCT05059236) | Bayer | 2021-11-04 |
| A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy (NCT04905212) | RemeGen Co., Ltd. | 2021-11-04 |
| Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial (NCT05046561) | Eyecheck, Inc. | 2021-11-04 |
| Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma (NCT04699461) | ADC Therapeutics S.A. | 2021-11-04 |
| Optimizing the Delivery of HIV nPEP (NCT03259698) | Unity Health Toronto | 2021-11-04 |
| Cetuximab in Third Line for Mutant APC, TP53 and RAS Patients With Refractory Metastatic Colorectal Cancer (NCT04853043) | University of Utah | 2021-11-03 |
| A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis (NCT04915950) | Pfizer | 2021-11-03 |
| A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis (NCT06035354) | Akeso | 2021-11-03 |
| A Study of AK109 Combined With AK104 in Patients With Advanced Solid Tumors (NCT05142423) | Akeso | 2021-11-03 |
| Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers (NCT05099549) | NKGen Biotech, Inc. | 2021-11-03 |
| Study of Capivasertib in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT05008055) | AstraZeneca | 2021-11-03 |
| Restrictive Fluid Administration vs. Standard of Care in Emergency Department Sepsis Patients (NCT05076435) | Marie Kristine Jessen, MD | 2021-11-03 |
| A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus Infection (NCT05005507) | Janssen Research & Development, LLC | 2021-11-03 |
| Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery (NCT04597372) | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 2021-11-03 |
| SHAPE of Portal Hypertension in Children (NCT04720456) | Thomas Jefferson University | 2021-11-03 |
| A Phase Ib/II Study of GT90001 Combined With KN046 in Solid Tumors (NCT04984668) | Suzhou Kintor Pharmaceutical Inc, | 2021-11-02 |
| GI Permeability Change in Response to Aquamin® (NCT04855799) | James Varani | 2021-11-02 |
| A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors (NCT05001347) | I-Mab Biopharma US Limited | 2021-11-02 |
| Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA) (NCT05027633) | M.D. Anderson Cancer Center | 2021-11-02 |
| Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK (NCT05164393) | Coegin Pharma AB | 2021-11-02 |
| Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia (NCT05297201) | Celon Pharma SA | 2021-11-02 |
| Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma (NCT04871607) | City of Hope Medical Center | 2021-11-02 |
| A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006) (NCT04980872) | Merck Sharp & Dohme LLC | 2021-11-02 |
| NBT-NM108 as an Early Treatment for Suspected or Confirmed Symptomatic COVID-19 Patients (NCT04540406) | Notitia Biotechnologies Company | 2021-11-02 |
| Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (NCT04681677) | Xoft, Inc. | 2021-11-02 |
| Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®) (NCT05099965) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-11-02 |
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity (NCT04815967) | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 2021-11-02 |
| Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression (NCT05163041) | BicycleTx Limited | 2021-11-02 |
| Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency (NCT04240054) | Medical College of Wisconsin | 2021-11-02 |
| A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular Pathology (NCT04798989) | Tisento Therapeutics | 2021-11-02 |
| First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia (NCT05374278) | David Wilson | 2021-11-02 |